EcoDrugPlus

Interleukin-1 Receptor-Associated Kinase 4

Ensembl ID : ENSOSIG00000023217
Gene Symbol: IRAK4
1 Cross references
202 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSOSIG00000010419
Gene Symbol: IDH1
1 Cross references
234 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSOSIG00000004117
Gene Symbol: IDH2
1 Cross references
207 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSOSIG00000012453
Gene Symbol: IDH2
1 Cross references
186 Possible Orthologues:

Kelch-Like Ech-Associated Protein 1b

Ensembl ID : ENSOSIG00000022855
Gene Symbol: KEAP1B
1 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor (A Type Iii Receptor Tyrosine Kinase)

Ensembl ID : ENSOSIG00000007139
Gene Symbol: KDR
1 Cross references
197 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSOSIG00000020503
Gene Symbol: KIF5B
1 Cross references
234 Possible Orthologues:

Lectin, Galactoside Binding Soluble 3a

Ensembl ID : ENSOSIG00000017180
Gene Symbol: LGALS3A
1 Cross references
220 Possible Orthologues:

Leukotriene B4 Receptor

Ensembl ID : ENSOSIG00000021309
Gene Symbol: LTB4R
1 Cross references
142 Possible Orthologues:

Leukotriene B4 Receptor 2b

Ensembl ID : ENSOSIG00000018456
Gene Symbol: LTB4R2B
1 Cross references
166 Possible Orthologues:

Leukotriene B4 Receptor 2b

Ensembl ID : ENSOSIG00000005651
Gene Symbol: LTB4R2B
1 Cross references
166 Possible Orthologues:

Lysine (K)-Specific Demethylase 1a

Ensembl ID : ENSOSIG00000013011
Gene Symbol: KDM1A
1 Cross references
212 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).